We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.
Otolaryngology - Head & Neck Surgery

You are here

Human Papilloma Virus (HPV)

In recent years, infection with the Human Papilloma Virus (HPV) has emerged as a major cause of oropharynx cancer including cancer of the tonsils and base of tongue. In fact, according to the Centers for Disease Control, more than 70 percent of the oropharyngeal cancer diagnosed in the United States is now linked to HPV with the percentage expected to continue to climb. Oropharyngeal tumors driven by HPV have an improved prognosis compared with cancers not associated with HPV. At Weill Cornell, we have significant experience and expertise in the diagnosis and management of HPV related oropharyngeal cancer. We practice a patient centered approach which benefits from the ability to offer multiple treatment modalities including transoral robotic surgery (TORS), transoral laser surgery (TLM), as well as state of the art radiation and chemotherapy. We are also actively researching the ability to de-escalate therapy to maintain high cure rates while reducing the toxicity and side-effects of treatment.

(646) 962-3681

Weill Cornell Medicine Otolaryngology - Head & Neck Surgery

Human Papilloma Virus (HPV)
1305 York Ave., Fifth Floor New York, NY 10022